Page 76 - Read Online
P. 76

Page 4 of 15                                                 Song et al. Hepatoma Res 2020;6:27  I  http://dx.doi.org/10.20517/2394-5079.2020.05


               HBV DNA integration
               HBV DNA integration occurs early once HBV entering into hepatocytes and remains stable throughout
               tumor progression, which explains the existence of monoclonal or polyclonal origins of HCC from the
               view of virus infection [45,46] . HBV DNA susceptibly integrates into rare fragile sites or functional genomic
               regions, which are proximate to protein coding or non-coding genes. Functionally, the protein-coding genes
               are deeply associated with tumorigenesis and the non-coding genes are involved in telomere maintenance,
               protein modification processes, and chromosome localization [47-49] . For example, integration drives mutation
               in tumor suppressor gene ZNF717 and over-expression of critical oncogene c-MYC. Meanwhile, integration
               into intron of cyclin A2 generates a pseudo-exon forming a chimeric fusion with CCNA2, which encodes
               protein promoting cell cycle progression [46,50,51] . Moreover, HBV DNA integration is closely correlated with
               gender-bias and recurrence of HCC. Androgen receptor, but not estrogen receptor, enhances transcription
               responsive of TERT promoter with HBV integration to sex hormones via hepatocyte nuclear factor 4 alpha
                                         [52]
               (HNF4α)- dependent manner . Multiple studies have identified fragile integration sites more in non-
               cancerous tissue than those in neoplastic tissues, which implies tumor recurrence [48,53] .

               Genomic instability
               In infected hepatocytes, both HBV DNA integration and viral proteins lead to genomic instability.
               Sequencing analysis of 373 liver cancer samples demonstrated ultra-high structural instability and preserved
                                                   [54]
               un-methylation in HBV integrated regions . HBx directly induces genomic instability via inhibiting mono-
               ubiquitylation of an evolutionarily conserved E3 ligase and impairing homologous recombination, which
                                      [55]
               contribute to tumorigenesis . LHBs are the major viral protein leading to genomic instability. By inducing
               DNA damage and G2/M checkpoint failure, LHBs promote formation of hepatocyte aneuploidy and further
               self-propagating cycles of chromosomal instability, which drives cellular heterogeneity and clonal cancer
               evolution [56,57] .


               NAFLD
               NAFLD and its complication nonalcoholic steatohepatitis (NASH) are becoming the leading cause of
               HCC. Multiple pathways, such as abnormal metabolism, dysbiosis of gut microbiota and dysregulated
               immune responses, are involved in NAFLD initiated hepatocarcinogenesis and have been well summarized
                      [58]
               recently . Here, we mainly focus on dysregulated pathway mediated by lipid accumulation which is
               fundamental in progression of NAFLD related HCC. The abnormal intrahepatic lipid metabolism invokes
               insulin resistance, alteration of signaling pathways and oncogenes, followed by inflammation, fibrogenesis
               and hepatocarcinogenesis. In clinical samples, level of p-STAT5 is positively correlated with expression of
               sterol regulatory element binding protein-1 (SREBP1) and further in vivo and in vitro essays demonstrate
               that mTORC1 interacts and phosphorylates STAT5 to upregulate expression of lipogenetic genes, including
                                                                              [59]
               SREBP1, fatty acid synthase (FASN) and acetyl-CoA carboxylase (ACC) . Both oxidative and ER stress
               caused by chronic lipotoxicity play critical roles in NAFLD-HCC. Oxidized LDL (oxLDL) uptake triggers
               CEBPβ expression to directly upregulate Nogo-B, an ER-residential protein, and promote lipophagy leading
                                                                   [60]
               to lysophosphatidic acid-enhanced YAP oncogenic activity . In addition to hippo signaling pathway,
               STAT3-mediated pathways are frequently involving in pathogenesis of NAFLD-HCC, which mediated lipid
               accumulation, apoptosis and fibrogenesis [61-66] .


               Other than metabolic disorder, gene polymorphism is significantly responsible for NAFLD. Recent genome-
               wide association studies (GWASs) in European ancestry suggest a robust relationship of PNPLA3 gene cluster
               with NAFLD activity, progression to HCC and liver-associated death [67-69] . This study also demonstrated
                                                                                                       [67]
               an association of novel loci near IL17RA and ZFP90-CDH1 with NAFLD disease severity and fibrosis .
               rs368234815 variant in IFNL4 and FNDC5 rs3480 polymorphism are respectively identified to be associated
               with liver damage and fibrosis in patients with NAFLD [70,71] . In addition, gender-bias is as well  observed in
               NAFLD-HCC. As the confirmed risk factor for male HCC, androgen receptor (AR) transcription activity is
               enhanced by key enzymes and specific unsaturated fatty acid produced in lipogenesis via activation of Akt
                    [72]
               kinase  [Figure 1].
   71   72   73   74   75   76   77   78   79   80   81